Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 503 (abbreviated as RNA5SP503 or RN5S503) is a pseudogene—a DNA sequence related to the functional 5S ribosomal RNA gene but rendered non-functional due to mutations or degeneration. Pseudogenes are classified based on their loss of the ability to encode functional products and are often designated by the presence of features such as lack of regulatory elements or critical sequence changes[2][4][5]. RNA5SP503 does not produce a functional RNA or protein, does not participate in ribosome structure or function, and is not a receptor, enzyme, or therapeutic target. It is annotated in genomic resources for tracking genomic evolution and has no known biological or clinical role. - Note: The name, function, and classification indicate this is not a druggable or therapeutic target, nor a receptor, enzyme, or signaling molecule; it is a non-functional genomic element[2][5]. The presence of “pseudogene” in the canonical name means it cannot be considered a molecular or therapeutic target in pharmacology or biomedicine. - The entry is "incorrect" for most target analyses because pseudogenes are not functional targets for drugs or therapeutics, and the target name may be confused with the functional 5S rRNA gene or ribosomal RNA itself, which is biologically essential[1][5]. Summary of major points: - RNA5SP503 is a 5S ribosomal RNA pseudogene. - It has no biological function, no drug interactions, and no disease associations. - It is not a therapeutic target and should be flagged as an incorrect or ineligible target for biomedical or drug discovery purposes.
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 503 (RNA5SP503).